COVID-19: Vaccines and Therapeutics
Photo Credit: Southwest Health System
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine for administration in adolescents ages 12 to 15.
The Federal Emergency Management Agency is reminding stakeholders that funding is available under FEMA’s Public Assistance program, including for community engagement and information dissemination to promote vaccination availability, scheduling, and accessibility, as well as reimbursement for…
The Centers for Medicare & Medicaid Services released an interim final rule requiring long-term care facilities in the Medicare and Medicaid programs to offer the COVID-19 vaccine to residents and staff, educate them on the benefits and potential side effects, and begin reporting weekly COVID-…
The Food and Drug Administration announced the expansion of its emergency use authorization for Pfizer’s COVID-19 vaccine to include adolescents ages 12 to 15.
Illinois health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence in Illinois of the SARS-CoV-2 P.1 variant, which is not susceptible to the combination therapy, the Office of the Assistant Secretary for…
AtlantiCare relies on efficient and effective collaboration and communication to vaccinate communities.
A team of doctors and scientists at UVA Health answers the public’s questions about deployment, efficacy and safety of all COVID-19 vaccines.
Armed with his guitar, a physician has been entertaining people getting their shots at the Mary Washington Healthcare COVID-19 vaccine clinic.
Effective immediately, Medicare will pay $750 to administer monoclonal antibodies to COVID-19 patients in their residence or temporary lodging and increase payment to administer them in most other care settings to $450 from $310 to better align payment with provider costs, the Centers for Medicare…